Imedex would like to offer a special thank you to those organizations that have provided support to the 2017 Advances in IBD Conference through an educational grant.

AbbVie Inc.
Celgene Corporation
Gilead Sciences, Inc.
Salix Pharmaceuticals, Inc., A Division of Valeant Pharmaceuticals North America LLC
Takeda Pharmaceuticals U.S.A., Inc
UCB, Inc.


Several options are available to companies interested in supporting this conference.

For educational grant support or questions, please contact:

Dorothy Germino
+1 (678) 242-0855

For exhibits and other support opportunities, please contact:

Stacy S. Brandau
+1 (404) 384-8416